SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Unitedhealth Group Inc – ‘8-K’ for 3/10/20

On:  Tuesday, 3/10/20, at 4:36pm ET   ·   For:  3/10/20   ·   Accession #:  731766-20-18   ·   File #:  1-10864

Previous ‘8-K’:  ‘8-K’ on / for 1/15/20   ·   Next:  ‘8-K’ on / for 4/15/20   ·   Latest:  ‘8-K/A’ on 4/24/24 for 2/21/24

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 3/10/20  Unitedhealth Group Inc            8-K:7       3/10/20   13:207K

Current Report   —   Form 8-K   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     30K 
12: R1          Cover                                               HTML     44K 
 7: R2          Cover Non-Printing                                  HTML     11K 
10: XML         IDEA XML File -- Filing Summary                      XML     13K 
 9: XML         XBRL Instance -- a2020barclays8-k_htm                XML     15K 
 8: EXCEL       IDEA Workbook of Financial Reports                  XLSX      7K 
 3: EX-101.CAL  XBRL Calculations -- unh-20200310_cal                XML      7K 
 4: EX-101.DEF  XBRL Definitions -- unh-20200310_def                 XML     36K 
 5: EX-101.LAB  XBRL Labels -- unh-20200310_lab                      XML     77K 
 6: EX-101.PRE  XBRL Presentations -- unh-20200310_pre               XML     42K 
 2: EX-101.SCH  XBRL Schema -- unh-20200310                          XSD     17K 
11: JSON        XBRL Instance as JSON Data -- MetaLinks               14±    20K 
13: ZIP         XBRL Zipped Folder -- 0000731766-20-000018-xbrl      Zip     15K 


‘8-K’   —   Current Report


This is an HTML Document rendered as filed.  [ Alternative Formats ]



 iX:   C:   C:   C: 
  Document  
 i false i 0000731766 0000731766 2020-03-10 2020-03-10


 
 
 
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
—————————————
FORM  i 8-K
—————————————
Current Report
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of report (Date of earliest event reported):  i March 10, 2020
—————————————
 i UNITEDHEALTH GROUP INCORPORATED
(Exact name of registrant as specified in its charter)
—————————————
 i Delaware
 
 i 1-10864
 
 i 41-1321939
(State or other jurisdiction of incorporation)
 
(Commission File Number)

 
(I.R.S. Employer Identification No.)

 i UnitedHealth Group Center, 9900 Bren Road East,
 i Minnetonka,
 i Minnesota
 i 55343
(Address of principal executive offices)
(Zip Code)
Registrant’s telephone number, including area code: ( i 952)  i 936-1300
N/A
(Former name or former address, if changed since last report.)
—————————————
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 i  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 i  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 i  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 i  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
 
Trading Symbol(s)
 
Name of each exchange on which registered
 i Common Stock, $.01 par value
 
 i UNH
 
 i New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
 i  Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
 
 
 
 
 




Item 7.01.
Regulation FD Disclosure.

Senior leaders from UnitedHealth Group Incorporated (the "Company") will respond to questions in an interview format, including discussion of the Company’s strategy, market positions, recent results and expectations for its end markets, at the Barclays Global Healthcare Conference on Thursday, March 12, 2020 beginning at 9:30 a.m., Eastern Time.

A live audio webcast of the presentation will be made available through the Investors page of the Company’s website at www.unitedhealthgroup.com.

The information in this Item 7.01 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any Company filing under the Securities Act of 1933 or the Securities Exchange Act of 1934, except as shall be expressly set forth by specific reference in such filing.




SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: March 10, 2020                 
 
 
 
UNITEDHEALTH GROUP INCORPORATED
 
 
 
By:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Secretary to the Board of Directors



Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘8-K’ Filing    Date    Other Filings
3/12/20None on these Dates
Filed on / For Period end:3/10/20
 List all Filings 
Top
Filing Submission 0000731766-20-000018   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., Apr. 26, 10:50:51.1am ET